References
- Rees DC, Gibson JS. Biomarkers in sickle cell disease. Br J Haematol. 2012;156(4):433–445
- Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. Am J Hematol. 2012;87(8):795–803
- Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031
- Serjeant GR, Serjeant BE, Forbes M, et al. Haemoglobin gene frequencies in the Jamaican population: A study in 100,000 newborns. Br J Haematol. 1986;64(2):253–262
- Ngo DA, Aygun B, Akinsheye I, et al. Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for Haemoglobin S and deletional hereditary persistence of fetal haemoglobin. Br J Haematol. 2012;156(2):259–264
- Talbot JF, Bird AC, Serjeant GR. Retinal changes in sickle cell/hereditary persistence of fetal haemoglobin syndrome. Br J Ophthalmol. 1983;67(11):777–778
- Whyte D, Forget B, Chui DHK, et al. Massive splenic infarction in an adolescent with Hemoglobin S-HPFH. Pediatr Blood Cancer. 2013;60(7):E49–E51
- Craig JE, Barnetson RA, Prior J, et al. Rapid detection of deletions causing δβ thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification. Blood. 1994;83(6):1673–1682
- Tan AS, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for α-thalassemia. Blood. 2001;98(1):250–251
- Sarray S, Saleh LR, Lisa Saldanha F, et al. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition. Cytokine. 2015;72(1):43–47
- Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364(9442):1343–1360
- Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339(1):5–11
- Edington GM, Lehmann H. Expression of the sickle-cell gene in Africa. BMJ. 1955;1(4925):1308–1311
- Jacob GF, Raper AB. Hereditary persistence of foetal haemoglobin production, and its interaction with the sickle-cell trait. Br J Haematol. 1958;4(2):138–149
- Conley CL, Weatherall DJ, Richardson SN, et al. Hereditary persistence of fetal hemoglobin: A study of 79 affected persons in 15 Negro families in Baltimore. Blood. 1963;21(3):261–281
- Rubin EM, Rowley PT. Sickle cell trait/hereditary persistence of fetal hemoglobin trait. Misdiagnosis as sickle cell anemia by newborn screening. Am J Dis Child. 1979;133(12):1248–1250
- Steinberg MH, Chui DHK, Dover GJ, et al. Fetal hemoglobin in sickle cell anemia: A glass half full? Blood. 2014;123(4):481–485
- Murray N, Serjeant BE, Serjeant GR. Sickle cell-hereditary persistence of fetal haemoglobin and its differentiation from other sickle cell syndromes. Br J Haematol. 1988;69(1):89–92
- Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med. 1992;326(9):605–610
- Deane CR, Goss D, O’Driscoll S, et al. Transcranial Doppler scanning and the assessment of stroke risk in children with HbSC [corrected] disease. Arch Dis Child. 2008;93(2):138–141
- Adams RJ. Big strokes in small persons. Arch Neurol. 2007;64(11):1567–1574